A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
What can I say that [UltraLong] and others haven't... this stock is imaginary, hype, inflated, unrealistic, but also very much loved. Why? dreams. Why not? Reality.
Seriously, I believe that the company may prove good, but not THAT good to be worth this crazy valuation, even if it does develop a drug. One drug doesn't get you to mid-caps, sorry.